Francesco Panzuto


Titolo Pubblicato in Anno
Evaluation of the relationships between computed tomography features, pathological findings, and rrognostic risk assessment in gastrointestinal stromal tumors JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY 2017
Impact of Ki67 re-assessment at time of disease progression in patients with pancreatic neuroendocrine neoplasms PLOS ONE 2017
Functional imaging in the follow-up of enteropancreatic neuroendocrine tumors: Clinical usefulness and indications THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 2017
Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 2017
Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors CANCER MEDICINE 2017
Lack of association for reported endocrine pancreatic cancer risk Loci in the PANDoRA consortium CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2017
Stage IV gastro-entero-pancreatic neuroendocrine neoplasms. A risk score to predict clinical outcome THE ONCOLOGIST 2017
Everolimus in pancreatic neuroendocrine carcinomas G3 PANCREAS 2017
Antiproliferative effect of somatostatin analogs in advanced gastro-entero-pancreatic neuroendocrine tumors. a systematic review and meta-analysis ONCOTARGET 2017
A case of pancreatic small cell neuroendocrine carcinoma associated with SIADH PANCREAS 2016
Digestive neuroendocrine neoplasms. A 2016 overview DIGESTIVE AND LIVER DISEASE 2016
Controversies in the treatment of digestive neuroendocrine tumors JOURNAL OF CANCER METASTASIS AND TREATMENT 2016
Risk and protective factors for small intestine neuroendocrine tumors: a prospective case-control study NEUROENDOCRINOLOGY 2016

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma